Home

ERIC BJERKHOLT

CIK 1197350 · CHIEF FINANCIAL OFFICER · last filed 2026-08-12

ERIC BJERKHOLT is a CHIEF FINANCIAL OFFICER who has filed 126 SEC Form 4 insider transactions across 13 companies since 2007. The most recent filing shows the insider sold $599.5K of MIRM on Aug 12, 2026. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.23M

Companies

13

Total Filings

126

Lifetime Open-Market Net

-$2.68M

Filer Profile

Reported Address
132 PURDURE AVENUE
KENGSINGTON, CA 94708
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MIRM CHIEF FINANCIAL OFFICER 36,355 $98.22 $3.57M -$2.91M 18 2026-08-12
MGX Director — $1.16 — $0 3 2026-06-11
CERS Director 261,679 $2.49 $651.6K $37.5K 17 2026-06-11
Surrozen, Inc./DE (SRZNW) Delisted Director — $0.00 — $0 4 2026-05-14
CalciMedica, Inc. (SCPH) Delisted Director — $5.67 — $0 1 2024-08-28
CALC Director 707 $1.98 $1.4K $6.7K 7 2024-04-22
CHINOOK THERAPEUTICS, INC. (KDNY) Delisted Chief Financial Officer 0 $40.39 $0 -$231.7K 9 2023-08-11
CalciMedica, Inc. (GRAY) Delisted Director — $5.50 — $0 3 2022-06-03
COLL Chief Financial Officer 0 $22.75 $0 $316.9K 15 2020-10-14
Corium International, Inc. (CORI) Delisted Director 0 — — $89.2K 6 2018-11-28
Viracta Therapeutics, Inc. (SNSS) Delisted EVP, CFO & Corp. Secretary 10,683 $18.62 $198.9K $20.2K 23 2016-12-06
STEM Director 1,521 $4.72 $7.2K $0 12 2016-01-05
Viracta Therapeutics, Inc. (SNSSD) Delisted Sr. VP, CFO & Corp. Secretary 84,582 — — $0 1 2011-03-02

Recent Filings

126 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-12 MIRM Sell (S) −6,001 -$599.5K EDGAR
2026-08-11 MIRM Notice (144) −6,001 -$599.5K EDGAR
2026-07-08 MIRM Sell (S) −5,000 -$611.3K EDGAR
2026-07-06 MIRM Notice (144) −5,000 -$611.3K EDGAR
2026-06-11 CERS Sell (S) −20,454 -$53.2K EDGAR
2026-06-11 MGX Grant (A) — $0 EDGAR
2026-06-09 CERS Notice (144) −20,454 -$53.2K EDGAR
2026-06-09 MIRM Mixed −2,607 -$405.7K EDGAR
2026-06-08 MIRM Notice (144) −5,000 -$469.1K EDGAR
2026-06-02 CERS Grant (A) +60,000 $0 EDGAR
Showing 1–10 of 126
Page 1 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.